Bacterial News and Research

RSS

LSUHSC researchers study common STI

Research led by David H. Martin, MD, Professor and Chief of Infectious Diseases at LSU Health Sciences Center New Orleans, has found that a common sexually transmitted infection-causing parasite "cultivates" bacteria beneficial to it, changing thinking about which comes first-infection or bacteria.

3 Apr 2013

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

2 Apr 2013

Report highlights ecological cost of pharmaceutical waste

Pharmaceuticals commonly found in the environment are disrupting streams, with unknown impacts on aquatic life and water quality.

2 Apr 2013

Post-disinfection clips retain aerobic and anaerobic bacteria, says study

Researchers at Tufts University School of Dental Medicine and the Forsyth Institute published a study today that found that a significant proportion of dental bib clips harbored bacteria from the patient, dental clinician and the environment even after the clips had undergone standard disinfection procedures in a hygiene clinic.

2 Apr 2013

New technique for vaccine design could prove useful against HIV, other viral strains

A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against HIV and other fast-changing viruses.

30 Mar 2013

New concept to fight microorganisms can promote stronger immune system

Managing bacteria and other microorganisms in the body, rather than just fighting them, may be lead to better health and a stronger immune system, according to a Penn State biologist.

29 Mar 2013

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Inflammation can be thought of as taking two major forms: acute or chronic. Acute inflammation, which can be painful, usually arises quickly and resolves quickly. It accompanies bacterial infections, traumatic injury and is useful to fight infections and promote healing.

28 Mar 2013

Sugar overloads on Easter can pose serious risks to children's health, Vanderbilt experts say

As Easter approaches, many parents may not want their children indulging in candy-filled eggs and Easter baskets full of sugary treats. Too much sugar can pose serious risks to children's dental and behavioral health, risks that can be minimized by some careful thought and planning, Vanderbilt experts say.

28 Mar 2013

Microbiologists identify unique resistance mechanisms of E. coli to carbapenems

As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms of a clinical isolate of E. coli resistant to carbapenems.

27 Mar 2013

Penn researchers develop nanotechnology-inspired technique for diagnosing Lyme disease

Early diagnosis is critical in treating Lyme disease. However, nearly one quarter of Lyme disease patients are initially misdiagnosed because currently available serological tests have poor sensitivity and specificity during the early stages of infection.

27 Mar 2013

Erythromycin may provide benefit for patients with non-CF bronchiectasis

Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.

27 Mar 2013

Clinigen announces acquisition of Cardioxane from Novartis

Clinigen Group plc today announced the acquisition of Cardioxane (dexrazoxane) from Novartis for US$33 million in cash, payable in two tranches.

From Clinigen Group 26 Mar 2013

Study: Virus that causes cold sores may be associated with cognitive problems

The virus that causes cold sores, along with other viral or bacterial infections, may be associated with cognitive problems, according to a new study published in the March 26, 2013, print issue of Neurology, the medical journal of the American Academy of Neurology.

26 Mar 2013

Genome sequencing reveals drug-resistant bacteria are transmitted from animals to humans

Researchers have used whole genome sequencing to reveal if drug-resistant bacteria are transmitted from animals to humans in two disease outbreaks that occurred on different farms in Denmark.

26 Mar 2013

Researchers test protease inhibitors with potential for prevention, treatment of norovirus infection

A Kansas State University-led team is researching ways to stop the spread of norovirus, a contagious stomach illness that infects one in 15 Americans each year, according to the Centers for Disease Control and Prevention.

25 Mar 2013

Certain strains of lactobacillus bacteria can dampen production of toxic shock syndrome toxin 1

Certain Streptococci increase their production of toxic shock syndrome toxin 1, sometimes to potentially dangerous levels, when aerobic bacteria are present in the vagina. But scientists from the University of Western Ontario have discovered certain strains of lactobacillus bacteria are capable of dampening production of that toxin according to research published in the journal Applied and Environmental Microbiology.

25 Mar 2013

TOBI Podhaler receives FDA approval for cystic fibrosis patients with Pseudomonas aeruginosa

The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.

24 Mar 2013

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

Affinium Pharmaceuticals announced today that its Phase 2a clinical trial evaluating oral AFN-1252 in acute bacterial skin & skin structure infections demonstrated excellent efficacy and safety data, marking a significant proof-of-concept milestone for Affinium's first-in-class, novel antibiotic targeted against bacterial fatty acid biosynthesis inhibition (FabI inhibitors).

21 Mar 2013

Researchers develop dune infiltration system to treat coastal stormwater runoff for fecal bacteria

When it rains, untreated stormwater can sweep pollutants into coastal waters, potentially endangering public health. Now researchers from North Carolina State University have developed low-cost filtration systems that are concealed beneath sand dunes and filter out most of the bacteria that can lead to beach closures.

21 Mar 2013

New study may help develop targeted therapies for controlling tissue destruction

Stroke, heart attacks and numerous other common disorders result in a massive destruction of cells and tissues called necrosis. It's a violent event: As each cell dies, its membrane ruptures, releasing substances that trigger inflammation, which in turn can cause more cellular necrosis.

19 Mar 2013

Bacterial News and Research

LSUHSC researchers study common STI

Study: Pradaxa drug may increase risk and severity of viral infections

Report highlights ecological cost of pharmaceutical waste

Post-disinfection clips retain aerobic and anaerobic bacteria, says study

New technique for vaccine design could prove useful against HIV, other viral strains

New concept to fight microorganisms can promote stronger immune system

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Sugar overloads on Easter can pose serious risks to children's health, Vanderbilt experts say

Microbiologists identify unique resistance mechanisms of E. coli to carbapenems

Penn researchers develop nanotechnology-inspired technique for diagnosing Lyme disease

Erythromycin may provide benefit for patients with non-CF bronchiectasis

Clinigen announces acquisition of Cardioxane from Novartis

Study: Virus that causes cold sores may be associated with cognitive problems

Genome sequencing reveals drug-resistant bacteria are transmitted from animals to humans

Researchers test protease inhibitors with potential for prevention, treatment of norovirus infection

Certain strains of lactobacillus bacteria can dampen production of toxic shock syndrome toxin 1

TOBI Podhaler receives FDA approval for cystic fibrosis patients with Pseudomonas aeruginosa

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

Researchers develop dune infiltration system to treat coastal stormwater runoff for fecal bacteria

New study may help develop targeted therapies for controlling tissue destruction

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News